Literature DB >> 19152152

Human mesenchymal stromal cells from adult and neonatal sources: comparative analysis of their morphology, immunophenotype, differentiation patterns and neural protein expression.

J J Montesinos1, E Flores-Figueroa, S Castillo-Medina, P Flores-Guzmán, E Hernández-Estévez, G Fajardo-Orduña, S Orozco, H Mayani.   

Abstract

BACKGROUND: Bone marrow (BM) has been recognized as the main source of mesenchymal stromal cells (MSC); however, MSC have also been detected in umbilical cord blood (UCB) and placenta (PL). In the present study, we obtained MSC from these three sources and characterized them in a comparative manner.
METHODS: MSC were obtained from BM, UCB and PL samples and analyzed to determine their morphology, cell-surface antigen (Ag) expression and differentiation potential. Particular emphasis was placed on the expression of neural markers.
RESULTS: MSC were detected in 9/9, 11/104 and 5/5 samples from BM, UCB and PL, respectively. MSC populations comprised several morphologically distinct cell types, including neural-like cells. MSC were positive for 'mesenchymal' Ag (CD105, CD73 and CD90), although CD90 expression was very heterogeneous. Interestingly, CD13 expression was high in all three sources. In all cases, MSC showed osteogenic and chondrogenic differentiation; however, UCB MSC showed no adipogenic potential. Furthermore, MSC from UCB produced a different type of cartilage compared with MSC from BM and PL. It is noteworthy that in all three sources we detected the expression of neural proteins without any neural differentiation stimuli. A significant increase in the proportion of neural marker-positive MSC was observed in the presence of neural inducers. DISCUSSION: Our results indicate that PL may prove to be a more appropriate source for obtaining MSC than UCB, and suggest the possibility that a subpopulation of MSC may possess neural potential, which is favored by neural inducers.

Entities:  

Mesh:

Year:  2009        PMID: 19152152     DOI: 10.1080/14653240802582075

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  29 in total

1.  Genetic stability of bone marrow-derived human mesenchymal stromal cells in the Quantum System.

Authors:  Mark Jones; Marileila Varella-Garcia; Margaret Skokan; Steven Bryce; Jeffrey Schowinsky; Rebecca Peters; Boah Vang; Michelle Brecheisen; Thomas Startz; Nathan Frank; Brian Nankervis
Journal:  Cytotherapy       Date:  2013-08-28       Impact factor: 5.414

2.  In vitro evidence of the presence of mesenchymal stromal cells in cervical cancer and their role in protecting cancer cells from cytotoxic T cell activity.

Authors:  Juan J Montesinos; María de L Mora-García; Héctor Mayani; Eugenia Flores-Figueroa; Rosario García-Rocha; Guadalupe R Fajardo-Orduña; Marta E Castro-Manrreza; Benny Weiss-Steider; Alberto Monroy-García
Journal:  Stem Cells Dev       Date:  2013-06-14       Impact factor: 3.272

3.  Mesenchymal stromal cells from human perinatal tissues: From biology to cell therapy.

Authors:  Karen Bieback; Irena Brinkmann
Journal:  World J Stem Cells       Date:  2010-08-26       Impact factor: 5.326

4.  Improved Proliferative Capacity of NP-Like Cells Derived from Human Mesenchymal Stromal Cells and Neuronal Transdifferentiation by Small Molecules.

Authors:  Alejandro Aguilera-Castrejon; Herminia Pasantes-Morales; Juan José Montesinos; Lorena V Cortés-Medina; Marta E Castro-Manrreza; Héctor Mayani; Gerardo Ramos-Mandujano
Journal:  Neurochem Res       Date:  2016-11-02       Impact factor: 3.996

Review 5.  Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa.

Authors:  Ellie Rashidghamat; John A McGrath
Journal:  Intractable Rare Dis Res       Date:  2017-02

6.  Human umbilical cord-derived Schwann-like cell transplantation combined with neurotrophin-3 administration in dyskinesia of rats with spinal cord injury.

Authors:  Guo Yan-Wu; Ke Yi-Quan; Li Ming; Cai Ying-Qian; Jiang Xiao-Dan; Zhang Shi-Zhong; Zhang Wang-Ming; Duan Chuan-Zhi
Journal:  Neurochem Res       Date:  2011-01-18       Impact factor: 3.996

Review 7.  Adipose-Derived Mesenchymal Stem Cells in Autoimmune Disorders: State of the Art and Perspectives for Systemic Sclerosis.

Authors:  Alexandre T J Maria; Marie Maumus; Alain Le Quellec; Christian Jorgensen; Danièle Noël; Philippe Guilpain
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

8.  Human mesenchymal stromal cells from adult and neonatal sources: a comparative in vitro analysis of their immunosuppressive properties against T cells.

Authors:  Marta E Castro-Manrreza; Hector Mayani; Alberto Monroy-García; Eugenia Flores-Figueroa; Karina Chávez-Rueda; Victoria Legorreta-Haquet; Edelmiro Santiago-Osorio; Juan José Montesinos
Journal:  Stem Cells Dev       Date:  2014-02-24       Impact factor: 3.272

9.  The Epigenetic Regulator HDAC1 Modulates Transcription of a Core Cardiogenic Program in Human Cardiac Mesenchymal Stromal Cells Through a p53-Dependent Mechanism.

Authors:  Joseph B Moore; John Zhao; Matthew C L Keith; Alok R Amraotkar; Marcin Wysoczynski; Kyung U Hong; Roberto Bolli
Journal:  Stem Cells       Date:  2016-09-01       Impact factor: 6.277

Review 10.  Natural history of mesenchymal stem cells, from vessel walls to culture vessels.

Authors:  Iain R Murray; Christopher C West; Winters R Hardy; Aaron W James; Tea Soon Park; Alan Nguyen; Tulyapruek Tawonsawatruk; Lorenza Lazzari; Chia Soo; Bruno Péault
Journal:  Cell Mol Life Sci       Date:  2013-10-25       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.